The right time to measure anti-Xa activity in critical illness: pharmacokinetics of therapeutic dose nadroparin

Jelmer G Sytema, Bert G Loef, Harriët M Loovers, Marijn Boer, Daniël J Touw, Marinus van Hulst*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

2 Citations (Scopus)
69 Downloads (Pure)

Fingerprint

Dive into the research topics of 'The right time to measure anti-Xa activity in critical illness: pharmacokinetics of therapeutic dose nadroparin'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science